Latest SABBY MANAGEMENT, LLC Stock Portfolio
$148Billion– No. of Holdings #27
SABBY MANAGEMENT, LLC Performance:
2024 Q2: -11.58%YTD: -34.21%2023: -61.78%
Performance for 2024 Q2 is -11.58%, and YTD is -34.21%, and 2023 is -61.78%.
About SABBY MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, SABBY MANAGEMENT, LLC reported an equity portfolio of $148.7 Billions as of 30 Jun, 2024.
The top stock holdings of SABBY MANAGEMENT, LLC are VANI, , RDHL. The fund has invested 1.8% of it's portfolio in VIVANI MEDICAL INC and 0.5% of portfolio in CORE SCIENTIFIC.
The fund managers got completely rid off TONIX PHARMACEUTICALS HLDG (TNXP), GLOBAL MOFY METAVERSE LTD and RECON TECHNOLOGY LTD (RCON) stocks. They significantly reduced their stock positions in CHINA NATURAL RESOURCES INC (CHNR), ELTEK LTD and REDHILL BIOPHARMA LTD (RDHL). SABBY MANAGEMENT, LLC opened new stock positions in CORE SCIENTIFIC, GREENWAVE TECHNOLOGY (GWAV) and ISHARES TR (IJR). The fund showed a lot of confidence in some stocks as they added substantially to LIPELLA PHARMACEUTICALS INC (LIPO), ENSYSCE BIOSCIENCES INC (ENSC) and BIOVIE INC (BIVI).
The top stock holdings of SABBY MANAGEMENT, LLC are VANI, , RDHL. The fund has invested 1.8% of it's portfolio in VIVANI MEDICAL INC and 0.5% of portfolio in CORE SCIENTIFIC.
The fund managers got completely rid off TONIX PHARMACEUTICALS HLDG (TNXP), GLOBAL MOFY METAVERSE LTD and RECON TECHNOLOGY LTD (RCON) stocks. They significantly reduced their stock positions in CHINA NATURAL RESOURCES INC (CHNR), ELTEK LTD and REDHILL BIOPHARMA LTD (RDHL). SABBY MANAGEMENT, LLC opened new stock positions in CORE SCIENTIFIC, GREENWAVE TECHNOLOGY (GWAV) and ISHARES TR (IJR). The fund showed a lot of confidence in some stocks as they added substantially to LIPELLA PHARMACEUTICALS INC (LIPO), ENSYSCE BIOSCIENCES INC (ENSC) and BIOVIE INC (BIVI).
SABBY MANAGEMENT, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
SABBY MANAGEMENT, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that SABBY MANAGEMENT, LLC made a return of -11.58% in the last quarter. In trailing 12 months, it's portfolio return was -64.8%.
New Buys
| Ticker | $ Bought |
|---|---|
| core scientific | 762,073,000 |
| greenwave technology | 406,165,000 |
| ishares tr | 304,335,000 |
| reviva pharmaceutcls hldgs inc | 303,356,000 |
| sonnet biotherapeutics hldng inc | 223,495,000 |
| aptevo therapeutics inc | 153,459,000 |
| avenue therapeutics inc | 130,879,000 |
| effector therapeutics | 102,140,000 |
New stocks bought by SABBY MANAGEMENT, LLC
Additions
| Ticker | % Inc. |
|---|---|
| lipella pharmaceuticals inc | 116 |
| ensysce biosciences inc | 36.35 |
| biovie inc | 6.37 |
Additions to existing portfolio by SABBY MANAGEMENT, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| china natural resources inc | -75.55 |
| eltek ltd | -64.1 |
| redhill biopharma ltd | -42.17 |
| wearable devices ltd | -38.93 |
| gevo inc | -28.57 |
| vivani medical inc | -20.46 |
| neximmune inc | -16.62 |
| inmed pharmaceuticals inc | -15.06 |
SABBY MANAGEMENT, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| tonix pharmaceuticals hldg | -910,649,000 |
| recon technology ltd | -420,408,000 |
| core scientific inc | -1,244,120,000 |
| global mofy metaverse ltd | -527,607,000 |
| azitra inc | -87,390,000 |
| transcode therapeutics inc | -228,684,000 |
| scinai immunotherapeutics ltd | -131,377,000 |
| pineapple energy inc | -231,209,000 |
SABBY MANAGEMENT, LLC got rid off the above stocks
Sector Distribution
SABBY MANAGEMENT, LLC has about 65.2% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 65.2 |
| Healthcare | 24.8 |
| Industrials | 8 |
| Basic Materials | 1.9 |
Market Cap. Distribution
SABBY MANAGEMENT, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 65.2 |
| NANO-CAP | 33 |
| MICRO-CAP | 1.9 |
Stocks belong to which Index?
About 1.9% of the stocks held by SABBY MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 98.1 |
| RUSSELL 2000 | 1.9 |
SABBY MANAGEMENT, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SABBY MANAGEMENT, LLC
SABBY MANAGEMENT, LLC has 27 stocks in it's portfolio. About 4.1% of the portfolio is in top 10 stocks. EFTR proved to be the most loss making stock for the portfolio. GWAV was the most profitable stock for SABBY MANAGEMENT, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AKTX | akari therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMPG | amplitech group inc | 0.01 | 332,716 | 12,843,000 | reduced | -12.22 | ||
| APDN | applied dna sciences inc | 0.02 | 70,463 | 28,777,000 | new | |||
| APVO | aptevo therapeutics inc | 0.10 | 501,499 | 153,459,000 | new | |||
| ATXI | avenue therapeutics inc | 0.09 | 37,394 | 130,879,000 | new | |||
| ATXI | avenue therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUVI | applied uv inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCAN | bynd cannasoft enterprises inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCTX | briacell therapeutics corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BIVI | biovie inc | 0.20 | 73,305 | 293,589,000 | added | 6.37 | ||
| BJDX | bluejay diagnostics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BRTX | biorestorative therapies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BVXV | biondvax pharmaceuticals ltd | 0.03 | 17,828 | 49,562,000 | new | |||
| BVXV | scinai immunotherapeutics ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CHNR | china natural resources inc | 0.06 | 104,931 | 82,161,000 | reduced | -75.55 | ||
| CING | cingulate inc | 0.00 | 38,210 | 4,952,000 | reduced | -2.18 | ||
| EFTR | effector therapeutics | 0.07 | 352,084 | 102,140,000 | new | |||
| ENSC | ensysce biosciences inc | 0.11 | 314,353 | 159,220,000 | added | 36.35 | ||
| GCTK | glucotrack inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GEVO | gevo inc | 0.09 | 250,000 | 139,300,000 | reduced | -28.57 | ||